Myrdal U - Search Results

1

Compliance in teenagers with coeliac disease--a Swedish follow-up study.

Ljungman G, Myrdal U. Ljungman G, et al. Among authors: myrdal u. Acta Paediatr. 1993 Mar;82(3):235-8. doi: 10.1111/j.1651-2227.1993.tb12649.x. Acta Paediatr. 1993. PMID: 8495075 Free PMC article.

2

Oats to children with newly diagnosed coeliac disease: a randomised double blind study.

Högberg L, Laurin P, Fälth-Magnusson K, Grant C, Grodzinsky E, Jansson G, Ascher H, Browaldh L, Hammersjö JA, Lindberg E, Myrdal U, Stenhammar L. Högberg L, et al. Among authors: myrdal u. Gut. 2004 May;53(5):649-54. doi: 10.1136/gut.2003.026948. Gut. 2004. PMID: 15082581 Free PMC article. Clinical Trial.

3

Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.

Leppert J, Nilsson H, Myrdal U, Edvinsson L, Hedner T, Ringqvist I. Leppert J, et al. Among authors: myrdal u. Cardiovasc Drugs Ther. 1993 Dec;7(6):901-7. doi: 10.1007/BF00877725. Cardiovasc Drugs Ther. 1993. PMID: 8011569 Clinical Trial.

4

Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects.

Ringqvist A, Leppert J, Myrdal U, Ahlner J, Ringqvist I, Wennmalm A. Ringqvist A, et al. Among authors: myrdal u. Clin Physiol. 1997 May;17(3):269-77. doi: 10.1111/j.1365-2281.1997.tb00006.x. Clin Physiol. 1997. PMID: 9171967

5

Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon.

Leppert J, Myrdal U, Hedner T, Edvinsson L, Tracz Z, Ringqvist I. Leppert J, et al. Among authors: myrdal u. Angiology. 1994 Jul;45(7):637-45. doi: 10.1177/000331979404500707. Angiology. 1994. PMID: 8024163

6

Oral mercaptopurine in childhood leukemia: influence of food intake on bioavailability.

Lönnerholm G, Kreuger A, Lindström B, Myrdal U. Lönnerholm G, et al. Among authors: myrdal u. Pediatr Hematol Oncol. 1989;6(2):105-12. doi: 10.3109/08880018909034276. Pediatr Hematol Oncol. 1989. PMID: 2702064 Clinical Trial.

7

Magnesium sulphate increases plasma noradrenaline and neuropeptide-Y-like immunoreactivity.

Leppert J, Myrdal U, Hedner T, Edvinsson L, Tracz Z, Ringqvist I. Leppert J, et al. Among authors: myrdal u. Lancet. 1995 Nov 11;346(8985):1307-8. doi: 10.1016/s0140-6736(95)91917-1. Lancet. 1995. PMID: 7475761 No abstract available.

8

Magnesium sulphate infusion decreases circulating calcitonin gene-related peptide (CGRP) in women with primary Raynaud's phenomenon.

Myrdal U, Leppert J, Edvinsson L, Ekman R, Hedner T, Nilsson H, Ringqvist I. Myrdal U, et al. Clin Physiol. 1994 Sep;14(5):539-46. doi: 10.1111/j.1475-097x.1994.tb00412.x. Clin Physiol. 1994. PMID: 7820978 Clinical Trial.

9

Plasma and erythrocyte concentrations of mercaptopurine after oral administration in children.

Lönnerholm G, Kreuger A, Lindström B, Ludvigsson J, Myrdal U. Lönnerholm G, et al. Among authors: myrdal u. Pediatr Hematol Oncol. 1986;3(1):27-35. doi: 10.3109/08880018609031198. Pediatr Hematol Oncol. 1986. PMID: 3153216

10

Cold exposure increases cyclic guanosine monophosphate in healthy women but not in women with Raynaud's phenomenon.

Leppert J, Ringqvist A, Ahlner J, Myrdal U, Sørensen S, Ringqvist I. Leppert J, et al. Among authors: myrdal u. J Intern Med. 1995 May;237(5):493-8. doi: 10.1111/j.1365-2796.1995.tb00875.x. J Intern Med. 1995. PMID: 7738490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results